Q2 2026 Holdings
Filed 2026-08-14 | 35 holdings | $629.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $49.4M | 1,523,022 | 7.8% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $38.2M | 1,573,220 | 6.1% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $33.8M | 1,063,234 | 5.4% |
| First Tracks Biotherapeutics(TRAX) | ORD SHS | 337185102 | $30.5M | 1,514,000 | 4.8% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $29.6M | 2,227,917 | 4.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $29.3M | 512,000 | 4.7% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $29.0M | 2,001,282 | 4.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $26.6M | 440,000 | 4.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $26.1M | 223,312 | 4.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $24.6M | 230,331 | 3.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $24.5M | 288,089 | 3.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $24.3M | 1,110,000 | 3.9% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $22.5M | 714,885 | 3.6% |
| Kailera Therapeutics Inc(KLRA) | COMMON STOCK | 482931102 | $21.7M | 984,786 | 3.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $21.7M | 115,750 | 3.4% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $18.4M | 9,051,318 | 2.9% |
| Incyte Corp(INCY) | COM | 45337C102 | $17.6M | 155,000 | 2.8% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $16.5M | 891,881 | 2.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $14.6M | 750,000 | 2.3% |
| Faeth Therapeutics Inc(SNSE) | COM NEW | 81728A207 | $12.9M | 515,335 | 2.0% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $12.0M | 2,571,478 | 1.9% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $11.3M | 2,743,658 | 1.8% |
| Sol-Gel Technologies LTD(SLGL) | SHS NEW | M8694L137 | $10.3M | 139,445 | 1.6% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $10.2M | 1,443,333 | 1.6% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $10.1M | 4,134,969 | 1.6% |
| Inventiva SA(IVA) | ADS | 46124U107 | $10.0M | 2,657,997 | 1.6% |
| Camp4 Therapeutics Corp(CAMP) | COM | 13463J101 | $8.4M | 1,932,937 | 1.3% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $8.1M | 2,660,000 | 1.3% |
| Minerva Neurosciences Inc(NERV) | COM NEW | 603380205 | $7.9M | 1,419,000 | 1.3% |
| Promis Neurosciences Inc(PMN) | COM SHS | 74346M505 | $7.3M | 557,103 | 1.2% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $6.6M | 1,438,456 | 1.0% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $5.8M | 273,181 | 0.9% |
| Research Alliance Corp III | ORD SHS CL A | G75226103 | $5.4M | 500,000 | 0.8% |
| VTV Therapeutics Inc(VTVT) | CL A NEW | 918385204 | $3.2M | 85,192 | 0.5% |
| Imagenebio Inc(IMA) | COM | 45175G207 | $1.7M | 282,004 | 0.3% |